Travere Therapeutics Inc (TVTX) earnings · rev $490.7M
These earnings events as JSON? API free 100/dayTravere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
This TVTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TVTX revenue for 2025-12-31 was $490.7M. Net income was -$25.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. TVTX currently screens at market cap $1.33B.
When the next TVTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 110.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TVTX research stays on the stock page; the tape stays on the quote page.
TVTX earnings FAQ
What are TVTX's latest revenue and net income?
Latest cached Travere Therapeutics Inc (TVTX) revenue for Dec 31, 2025 was $490.7M. Net income was -$25.5M. Statements: https://lician.com/financials/tvtx
What is TVTX's latest diluted EPS?
Latest cached Travere Therapeutics Inc (TVTX) diluted EPS for Dec 31, 2025 was -$0.29.
What period does the latest TVTX earnings print cover?
The latest cached Travere Therapeutics Inc (TVTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TVTX revenue change from the prior cached period?
Cached Travere Therapeutics Inc (TVTX) revenue was up 110.5% from $233.2M (Dec 31, 2024) to $490.7M (Dec 31, 2025). Statements: https://lician.com/financials/tvtx
Where are TVTX earnings listed?
Cached earnings facts for Travere Therapeutics Inc (TVTX) are listed at https://lician.com/earnings/tvtx. Statements: https://lician.com/financials/tvtx
Not investment advice.